K Number
K120187
Manufacturer
Date Cleared
2012-04-06

(74 days)

Product Code
Regulation Number
892.2050
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Multi-Modality Image Fusion is a software application to be used by physicians in the clinic or hospital for 2-D and 3-D visualization, image registration, and fusion of MRI, CT and Ultrasound imaging modalities for mapping planning information across modalities. Additional software features include database management, data communication, surface rendering, segmentation, regions of interest (ROI) delineation, volumetric measurements, and data reporting.

Device Description

Multi-Modality Image Fusion (MMIF) is software, which comprises of two software components, which is referred to as offline and online. The offline component perfains to the preparation of gland and suspected lesion boundaries on a DICOM image file days or hours prior to the biopsy procedure. The online component fuses the DICOM image files, which were, prepared on the offline component, with a snap shot incoming TRUS image. Each of the two software components can work together or independently.

AI/ML Overview

The provided 510(k) summary for the Multi-Modality Image Fusion device does not contain a specific table of acceptance criteria or detailed results of a study proving the device meets those criteria. However, it does outline the types of tests performed and provides a general statement of success.

Based on the available information, here is a description of the acceptance criteria (inferred from the testing) and the study conducted:

1. Acceptance Criteria and Reported Device Performance

Since explicit acceptance criteria are not provided, they are inferred from the types of tests performed. The document states that "All product and engineering specifications were verified and validated" and that "All the above mentioned tests passed." This implies that the device successfully met the intended performance parameters for each test.

Acceptance Criteria (Inferred from Tests)Reported Device Performance
Functional/Hardware VerificationTests Passed
- Hardware VerificationSuccessfully verified the MMIF hardware.
- Online Software Application VerificationSuccessfully verified the online software application.
- Offline Software Application VerificationSuccessfully verified the offline software application.
Risk Mitigation VerificationTests Passed
- Risk Mitigation VerificationSuccessfully verified risk mitigation strategies.
Accuracy (Benchmarking)Tests Passed
- Registration Accuracy for Clinical DataDemonstrated accuracy in registration for clinical data.
- Phantom Volume MeasurementsDemonstrated accurate volume measurements using phantoms.
- Phantom Registration AccuracyDemonstrated accurate registration using phantoms.
System Performance (Static & Dynamic)Tests Passed
- Overall System PerformanceConfirmed static and dynamic performance of the complete system (both online and offline software on specified hardware) and compliance to specifications in a simulated real environment.

2. Sample Size Used for the Test Set and Data Provenance

The document mentions "clinical data collected from the hospital setting" for the "Registration Accuracy for Clinical Data (bench test)." However, the sample size for this test set (number of cases/patients) is not specified. The data provenance is generally stated as "clinical data collected from the hospital setting," indicating it is likely retrospective clinical data used for a bench test.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

The document does not specify the number of experts used or their qualifications for establishing the ground truth of the "clinical data" used in testing. It only mentions that the "offline software would be typically executed by Radiologists."

4. Adjudication Method for the Test Set

The document does not specify any adjudication method (e.g., 2+1, 3+1, none) for establishing ground truth on the test set.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size

A Multi-Reader Multi-Case (MRMC) comparative effectiveness study comparing human readers with AI assistance versus without AI assistance was not mentioned or described in the provided summary. The focus of the performance testing appears to be on the device's standalone accuracy and functionality.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

Yes, a standalone performance evaluation of the algorithm (referred to as "the new MMIF software") was performed. The "Testing and Performance Data" section describes "bench testing" activities conducted "to ensure the performance of the new MMIF software by verifying the accuracy of the specifications and simulating real customer data collected from the hospital setting." The registration accuracy and volume measurements were assessed for the software itself.

7. The Type of Ground Truth Used

The ground truth for the bench tests involved:

  • Simulated prostates in test phantoms: Used for "Phantom Volume Measurements" and "Phantom Registration Accuracy." This represents a controlled and precisely known ground truth.
  • "Clinical data collected from the hospital setting": Used for "Registration Accuracy for Clinical Data." The method for establishing ground truth for this clinical data (e.g., expert consensus, pathology, surgical outcomes) is not explicitly stated.

8. The Sample Size for the Training Set

The document does not specify a training set size. The summary focuses on device verification and validation, implying that the device was perhaps developed or configured based on various data, but the specific characteristics of a "training set" (in the machine learning sense) are not outlined.

9. How the Ground Truth for the Training Set Was Established

Since a training set is not explicitly mentioned, the method for establishing its ground truth is not provided. The device seems to be a software application for image processing and fusion, rather than a machine learning model that requires explicit training data in the context of this 510(k) summary. For software applications of this nature, ground truth is often implicitly established by the underlying physical principles of image registration algorithms and validated against physical models or existing clinical standards.

{0}------------------------------------------------

510(k) Summary

APR - 6 2012

510(k) Summary

Submitter's Name: Submitter's Address: Submitter's Telephone: Contact Name:

Date Summary was Prepared: Trade or Proprietary Name: Common or Usual Name: Classification Name:

Predicate Devices:

IGT, LLC dba Eigen 13366 Grass Valley Avenue, Grass Valley, CA 95945 530-274-1240 . William Mandel 21 Oct 2011

Multi-Modality Image Fusion Multi-Modality Image Fusion

System, Image Processing, Radiological, LLZ

Picture Archiving and Communications, 21CFR 892.2050

Device Name510(k) Number
SyntegraK041182
UniSynK081987
Aegis NavigationK093672
AbarisK053610

Intended Use

Multi-Modality Image Fusion is a software application to be used by physicians in the clinic or hospital for 2-D and 3-D visualization, image registration, and fusion of MRI, CT and Ultrasound imaging modalities for mapping planning information across modalities. Additional software features include database management, data communication, surface rendering, segmentation, regions of interest (ROI) delineation, volumetric measurements, and data reporting.

Description of the Device and Summary of the Technological Characteristics:

Multi-Modality Image Fusion (MMIF) is software, which comprises of two software components, which is referred to as offline and online. The offline component perfains to the preparation of gland and suspected lesion boundaries on a DICOM image file days or hours prior to the biopsy procedure. The online component fuses the DICOM image files, which were, prepared on the offline component, with a snap shot incoming TRUS image. Each of the two software components can work together or independently.

Offline Software

The offline software can delineate suspected areas of interest using visualization and save this data in a standard format, e.g. as a surface mesh in VTK or STL format. Furthermore, the

EIGEN

PREMARKET NOTIFICATION - MULTI-MODALITY IMAGE FUSION

{1}------------------------------------------------

offline software can ontionally delineate the gland boundary from a DICOM image, or other volumes where the boundary can be easily observed. This addition data is also saved in a standard format. e.g. surface mesh in VTK or STL or as a binary volume. This software would be typically executed by Radiologists.

Online Software

The online unit software is designed to fuse two images by entering a fusion mode and load the DICOM image and the boundary data provided by the offline unit. The online unit performs rigid alignment, either selecting globally align that orients the two DICOM volumes based on the known relative orientation difference between the two or specify landmarks to register images rigidly. The online unit then elastically warps the image to register on the incoming image from the offline unit.

The registered image volume is displayed on the incoming offline image frame of reference. Also overlaid on the incoming offline and registered image volumes annotating the suspected lesion boundaries. The two volumes are displayed side-by-side in a locked view. Rotation, slicing, panning, or zooming one of the volumes has the same effect on the other enabling visualization of similar features in both volumes simultaneously.

Plan targets on the volumes by selecting suitable locations within the suspected areas of interest boundary. When sufficient targets have been added, exiting fusion mode imports all targets planned in the offline frame of reference back to the original reconstructed ultrasound volume. This is done based on the deformation field that was estimated from registration (rigid followed by elastic registration).

Substantial Equivalence:

ManufacturerEigenADACLaboratoriesConvergentImagingSolutionsSentinelle MedicalInc.TraxtalTechnologies lhc.
ProductNameMulti-ModalityImage FusionSyntegraUniSynAegis NavigationAbaris
510(k)numberpendingK041182K081987K093672K053610
IntendedUseMulti-ModalityImage Fusion is asoftwareapplication used bySyntegra is asoftwareapplication formulti-modalityUniSyn is asoftwareapplication forimageThis deviceprovides two andthree-dimensionalimage review.ABARIS is astereotaxicaccessory forComputed

EIGEN

PREMARKET NOTIFICATION - MULTI-MODALITY IMAGE FUSION

{2}------------------------------------------------

physicians in theimage registrationregistration andmanipulation, andTomography
clinic or hospitaland diagnosticfusion displayanalysis tools to(CT), Magnetic
for 2-D and 3-Dfusion. Images areof scannedassist users inResonance, (MR),
visualization,registered andimage datascreening,Ultrasound (US),
multi-modalitydisplayed in afrom CT, PET,diagnosis, planningPositron Emission
image registration,"fused" (overlaidSPECT andand performingTomography
and fusion ofin the same spatialMR scanners.image-guided(PET), Single
medical images.orientation)UniSyn createsinterventionalPhoton Emission
Additionalformat to providemulti-planarprocedures.Computed
software featuresinclude databasecombinedreformat andSupported imagingTomography
functional andmaximummodalities include(SPECT),
management,anatomical dataintensityMagneticFluoroscopy,
communication.providingprojectionResonance (MR),Endoscopy and
surface rendering,different angulardisplays of theUltrasound (US),other imaging
segmentation, ROIperspectives fordata andSingle Photonsystems. it
delineation,interpretation byprovidesEmissiondisplays the
measurements, andtrainedmeasurementsComputedsimulated image
reporting.professionalssuch as area,Tomographyof a tracked
volume and(SPECT),insertion tool
StandardComputedsuch as a biopsy
Uptake ValuesTomography (CT),needle, guidewire
for user definedPositronor probe on a
regions on theEmissioncomputer monitor
imageTomographyscreen that shows
(PET),images of the
Fluoroscopy andtarget organs and
Endoscopy. Imagesthe current and the
and data areprojected future
received frompath of the
various imaginginterventional
systems and otherinstrument taking
sources such asinto account
calibrated spatialmovements of the
positioningpatient. This is
devices.intended for
This devicetreatment
provides theplanning and
capability tointra-operative
overlay annotationsguidance for
on 2D or 3Dsurgical
medical imageprocedures.
displays.The device also
These annotationssupports an
may represent theimage-free mode
position ofin which the
instrumentsproximity of the
including but notinterventional
limited to biopsydevice is
needles, guidancedisplayed relative
wires, imagingto another device.
probes or otherThe device is
tracked devices.intended to be
This device isused in clinical
intended to assistinterventions and
skilled medicalfor anatomical
professionals instructures where
skilled medicalprofessionals inclinical screeningandclinical screeningfor anatomicalstructures whereimaging iscurrently used forimaging is

.

510(k) Summary

.

EIGEN PREMARKET NOTIFICATION – MULTI-MODALITY IMAGE FUSION

.

. . . . .

,

.

{3}------------------------------------------------

510(k) Summary
interventions, foranatomicalstructures whereimaging iscurrently used forvisualizing suchstructures,including head andneck, breast,thoracic, andabdominalapplications(includingvisualizing suchprocedures. Thedevice is alsointended for usein clinicalinterventions todetermine theproximity ofone devicerelative toanother.
pelvis).Lossy compressedmammographicimages anddigitized filmscreen images mustnot be
reviewed forprimary imageinterpretations.Mammographicimages may onlybe interpretedusing
a FDA approvedmonitor that offersat least 5 MPixelresolution andmeets othertechnical
specificationsreviewed andaccepted by theFDA.
WhereUsedOffice settings inclinic or hospitalOffice settings inclinic or hospitalOffice settingsin clinic orhospitalNot specifiedclinicalinterventions
SoftwareDeviceYesYesYesYesYes
ImageRegistrationMulti-modalityimage registrationMulti-modalityimage registrationMulti-modalityimageregistrationMulti-modalityimage registrationYes
ImageFusion/OverlayDisplayFused overlay ofimages frommultiple modalitiesFused overlay ofimages frommultiplemodalitiesFusion overlayof images frommultiplemodalitiesoverlay of imagesfrom multiplemodalitiesYes
OpacityControlYesYesYesNot SpecifiedNot Specified
3-DRenderingYesYesYesYesYes
SurfaceRenderingYesYesYesYesYes
Regions ofinterestYesYesYesYesYes
ConfiguraYesYesYesYesYes

EIGEN

.

:

DIGE."
PREMARKET NOTIFICATION – MULTI-MODALITY IMAGE FUSION

·

{4}------------------------------------------------

510(k) Summary

ble image layouts
3DContouringYesNot SpecifiedYesYesYes
Export of3D contoursforplanningYesNot SpecifiedYesNot SpecifiedYes
ImageStorageandCommunicationDICOM, JPEGDICOM (check)DICOMDICOMDICOM
ModalitiesCT, MRI,UltrasoundPositron EmissionTomography(PET) andX-ray ComputedTomography(CT).CT, PET,SPECT andMR scannersMRI, US, SPECT,CT, PET,Fluoroscopy,Endoscopy andothersComputedTomography(CT), MagneticResonance, (MR),Ultrasound (US),Positron EmissionTomography(PET), SinglePhoton EmissionComputedTomography(SPECT),Fluoroscopy,Endoscopy andother imaging

The product's technical features are substantially equivalent to Syntegra (K041182). UniSyn (K081987), Aegis Navigation (K093672) and Abaris (K053610). The Multi-Modality Image Fusion is a software product that runs on PC-based workstations. Image data is input to the devices and used to generate 3-D views and perform image processing. Like the four predicate devices, the software has image measurement, multi-planar reformatting, segmentation and image registration abilities, fusion of images from different modalities, image storage and retrieval, as well as patient information management functions.

The Syntegra and UniSyn are software products that accept multiple image data types including magnetic resonance, and computed tomography. Aegis Navigation and Abaris are systems that accept multiple modalities that include magnetic resonance, computed tomography and ultrasound. The Multi-Modality Image Fusion has been designed for processing medical images in standard DICOM format. The system is composed of two modules: an offline and an online module for image fusion for planning a procedure.

EIGEN PREMARKET NOTIFICATION – MULTI-MODALITY IMAGE FUSION

{5}------------------------------------------------

Testing and Performance Data:

All product and engineering specifications were verified and validated. Test phantoms incorporating simulated prostates were developed and were used to verify system performance.

The device has been designed and manufactured to conform to the following standards:

ACRINEMA PS3.1-3.18 Digital Imaging and Communications in Medicine (DICOM)

ISO 14971 Application of Risk Management to Medical Devices

ISO 13485 Medical Devices - Quality Management Systems - Requirements For Regulatory purposes

The following tests were performed:

MMIF Hardware verification Test Procedure

MMIF Online Verification Test Procedure

MMIF Offline Software Application Verification Test Procedure .

MMIF Risk Mitigation Verification Test Procedure

Registration Accuracy for Clinical Data (bench test)

Phantom Volume Measurements (bench test)

Phantom Registration Accuracy (bench test)

All the above mentioned tests passed. Theses testing activities were conducted to establish the performance, safety, effectiveness, functionality usability, and reliability characteristics of the new device.

The purpose of the performance testing (bench testing) was to ensure the performance of the new MMIF software by verifying the accuracy of the specifications and simulating real customer data collected from the hospital setting.

The conducted verification tests have confirmed static and dynamic performance of the complete system consisting of both the online and off line software installed on specified hardware. Furthermore these tests establish compliance to the specification under conditions simulation real environment of use.

Conclusion:

The results of comparing the intended use, function, technological characteristics, mode of operation and specifications of the Multi-Modality Image Fusion with those of the two predicate devices demonstrate that the Multi-Modality Image Fusion is substantially

  • EIGEN
    PREMARKET NOTIFICATION – MULTI-MODALITY IMAGE FUSION

{6}------------------------------------------------

equivalent to existing products on the market today.

. . . .

.

ﺎ ﺳﮯ ﺍ

1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 -

·

The verification and validation testing included bench performance tests, functionality tests, and system test. All tests were successfully completed.

. '·

'

.

: :

EIGEN PREMARKET NOTIFICATION – MULTI-MODALITY IMAGE FUSION

. .

{7}------------------------------------------------

Image /page/7/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes forming its wing. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002

APR - 6 2012

IGT LCC dba Eigen % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services 1394 25th Street NW BUFFALO MN. 55313

Re: K120187

Trade/Device Name: Multi-Modality Image Fusion Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications System Regulatory Class: II Product Code: LLZ Dated: March 1, 2012 Received: March 2 2012

Dear Mr. Job:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls: Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must or uny 1 vict all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of

{8}------------------------------------------------

Page 2

medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely Yours,

Janine M. Morris

Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health

Enclosure

{9}------------------------------------------------

Indications for Use Form

510(k) Number (if known):

Device Name: Multi-Mogality Image Fusion

Indications for Use: Multi-Modality Image Fusion is a software application to be used by physicians in the clinic or hospital for 2-D and 3-D visualization, image registration, and fusion of MRI, CT and Ultrasound imaging modalities for mapping planning information across modalities. Additional software features include database management, data communication, surface rendering, segmentation, regions of interest (ROI) delineation, volumetric measurements, and data reporting.

Prescription Use (Part 21 CFR 801 Subpart D)X
AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE OF ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Division Sign-Off Office of In Vitro Diagnostic Devices Evaluation and Safety

510(k) K120187

1-2

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).